PharmaSource: The External Manufacturing Community Essential intelligence for biopharma outsourcing leaders | Trusted by 50,000+ professionals | Subscribe TOP STORIES Why the Least Expensive CDMO Could Cost the Most: A Procurement Leader’s Guide to Total Cost of Ownership Read More » Altruist Biologics Completes First Commercial PPQ Campaign on 20,000L Bioreactors Gland Pharma and Neuland Laboratories Form Long-Term CDMO Partnership for Sterile APIs Porton Advanced Secures China Drug Manufacturing License for Commercial CGT CDMO Services Altasciences Expands R&D Laboratory to Integrate Formulation and Analytical Testing Piramal Pharma Solutions Launches Spray Drying Suite for Peptide Development Niagen Bioscience Selects Evotec as CRO to Advance IND-Enabling Development for NB4168 in Ataxia Telangiectasia CordenPharma Completes Acquisition of AmbioPharm to Expand Peptide CDMO Network Enzene Introduces NeX to Expand Global Biologics Manufacturing Taysha Signs Commercial Supply Agreement with Catalent for TSHA-102 Integer to Be Acquired by KKR in $5.7 Billion Deal WuXi AppTec Reports 38.9% Revenue Growth in H1 2026 Genezen Partners with Raiden Science Foundation on UBA5 Gene Therapy Manufacturing Codis Completes Acquisition of Catalent’s Nottingham Facility AstraZeneca x BMS: What we know about the $400B merger talks Germany CDMO: Pharma Manufacturing Market Guide More news + insights Altruist Biologics Completes First Commercial PPQ Campaign on 20,000L Bioreactors Gland Pharma and Neuland Laboratories Form Long-Term CDMO Partnership for Sterile APIs Porton Advanced Secures China Drug Manufacturing License for Commercial CGT CDMO Services PODCASTS Why the Least Expensive CDMO Could Cost the Most: A Procurement Leader’s Guide to Total Cost of Ownership “One Size Doesn’t Fit All”: CRAMSN COO on Serving Biotechs and Big Pharma Under One Roof SPOTLIGHT Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success RESOURCES Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success UPCOMING EVENTS AI + Digital Maturity in Contract Manufacturing 2026 External Manufacturing Leaders Basel 2026 External Manufacturing Leaders Dublin 2026 CDMO Live Americas . October 20-21, Boston 2026
Why the Least Expensive CDMO Could Cost the Most: A Procurement Leader’s Guide to Total Cost of Ownership Read More »
Niagen Bioscience Selects Evotec as CRO to Advance IND-Enabling Development for NB4168 in Ataxia Telangiectasia
Why the Least Expensive CDMO Could Cost the Most: A Procurement Leader’s Guide to Total Cost of Ownership